๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Kanamycin A-Derived Cationic Lipids as Vectors for Gene Transfection

โœ Scribed by Matthieu Sainlos; Michelle Hauchecorne; Noufissa Oudrhiri; Samia Zertal-Zidani; Abderrahim Aissaoui; Jean-Pierre Vigneron; Jean-Marie Lehn; Pierre Lehn

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
514 KB
Volume
6
Category
Article
ISSN
1439-4227

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Aminoglycoside-derived cationic lipids a
Aminoglycoside-derived cationic lipids as efficient vectors for gene transfection in vitro and in vivo
โœ Philippe Belmont; Abderrahim Aissaoui; Michelle Hauchecorne; Noufissa Oudrhiri; ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 138 KB

## Abstract ## Background Cationic lipids are at present very actively investigated for gene transfer studies and gene therapy applications. Basically, they rely on the formation of DNA/lipid aggregates via electrostatic interactions between their cationic headgroup and the negatively charged DNA.

Novel non-viral vectors for gene deliver
Novel non-viral vectors for gene delivery: Synthesis of a second-generation library of mono-functionalized poly-(guanidinium)amines and their introduction into cationic lipids
โœ Gerardo Byk; Javier Soto; Christophe Mattler; Marc Frederic; Daniel Scherman ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 111 KB ๐Ÿ‘ 2 views

The development of new gene delivery technologies is a prerequisite towards gene therapy clinical trials. Because gene delivery mediated by viral vectors remains of limited scope due to immunological and propagation risks, the development of new non-viral gene delivery systems is of crucial importan

Syngeneic fibroblasts transfected with a
Syngeneic fibroblasts transfected with a plasmid encoding interleukin-4 as non-viral vectors for anti-inflammatory gene therapy in collagen-induced arthritis
โœ Natacha Bessis; Virginie Cottard; Nathalie Saidenberg-Kermanach; Delphine Lemeit ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 119 KB

## Background: No effective long-term treatment is available for rheumatoid arthritis. recent advances in gene therapy and cell therapy have demonstrated efficiency in collagen-induced arthritis (cia). interleukin-4 (il-4) is already known to be efficient in cia in systemic injection or administere